《医疗机构临床用血管理办法》实施后临床用血情况调查分析

Analysis of Changes of Clinical Blood Transfusion After Implementation of Administrative Measures for Medical Institution Clinical Blood Use

目的探讨《医疗机构临床用血管理办法》（以下简称管理办法）实施前后本院临床用血变化情况，观察相关法律法规实施对临床输血安全管理的效果。方法选择2012年1月至2013年4月，本院的3305份临床输血资料作为研究对象。按2012年8月1日管理办法实施前后分为实施前组（n=1718）和实施后组（n=1587）。分别对两组资料中，医院临床用血总量、主要成分血使用情况、人均用血量、手术患者人均用血量及临床用血医学文书资料书写情况进行统计、分析和比较。结果管理办法实施后，临床用血总量下降了16．2％；悬浮红细胞和血浆的用量分别下降7．8％和21．0％，与管理办法实施前比较，差异有统计学意义（P值均〈0．05）；人均输血量、人均输血浆量、手术患者人均输血量与管理办法实施前比较，差异有统计学意义（P值均〈o．05）；临床用血医学文书资料更趋完善；输血指征掌握得到进一步提高。结论认真贯彻执行国家输血相关法律法规，开展科学合理用血，对提高临床输血质量具有重要意义。

Objective To observe the effects of laws and regulations concerned on clinical blood transfusion safety, by analyzing the changes of our hospital＇s clinical blood transfusion before and after the implementation of Administrative Measures for Medical Institution Clinical Blood Use （AMMICBU）. Methods From January 2012 to March 2013, a total of 3305 medical records of patients who have received blood transfusions were included in this study. There were 1718 and 1587 medical records which before and after the performance of AMMICBU separately. Indexes which included total quantity of blood transfusion, the usage situation of main blood components, the per capita amount of blood transfusion, the per capita amount of plasma transfusion, the per capita amount of blood transfusion of surgical departments and the situations of clinical blood transfusion medical documents were investigated and analyzed. Results After the performance of the AMMICBU, the amount of clinical used blood, suspension red blood cells and plasma dropped 16.2%, 7.8 % and 21.0% separately. Statistically, the differences had some statistic significance （P〈0.05）. The differences of the per capita amount of blood transfusion, the per capita amount of plasma transfusion and the per capita amount of blood transfusion of surgical departments before and after the performance of the AMMICBU also had some statistic significance （P〈0.05）. The clinical blood medical books were more perfect and the capability of grasp of transfusion indications improved after the performance of the AMMICBU. Conclusions It is very important to improve the quality of clinical blood transfusion by strictly abiding by the national laws and regulations concerned for blood transfusion, and performing a scientific and reasonable policy of blood transfusion.